Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-16 · accession 0001209191-21-051759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-17 | 2021-08-16 | PHIO | Dispersyn Gerrit | Pres, CEO, Dir | P - Purchase | $1.63 | +6,000 | 95.3K | +7% | +$9,780 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2021-08-16 | P | A | 6,000 | $1.63 | 95,281 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |